期刊文献+

妊娠期血栓性血小板减少性紫癜一例

原文传递
导出
摘要 患者21岁,孕1产0,因"孕37+1周,头痛1 d,左侧肢体麻木20 min"于2013年5月6日入院.患者孕期在外院定期进行产科检查未发现异常,4月10日在当地医院行常规产科检查时发现血压偏高,为138/90 mm Hg(1 mm Hg=0.133 kPa),查尿蛋白(-),未予处理.
作者 龚洵 邓东锐
出处 《中华产科急救电子杂志》 2013年第3期57-59,共3页 Chinese Journal of Obstetric Emergency(Electronic Edition)
  • 相关文献

参考文献11

  • 1Mannucci PM,Canciani MT,Forza I. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor[J].{H}Blood,2001,(9):2730-2735.
  • 2George JN. How I treat patients with thrombotic thrombocytopenic purpura[J].{H}Blood,2010,(20):4060-4069.
  • 3Rozdzinski E,Hertenstein B,Schmeiser T. Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival[J].{H}Annals of Hematology,1992,(5):245-248.
  • 4阮长耿,余自强.2012版血栓性血小板减少性紫癜诊断与治疗中国专家共识解读[J].临床血液学杂志,2013,26(2):145-146. 被引量:31
  • 5Sadler JE. Von Willebrand factor,ADAMTS13 and thrombotic thrombocytopenic purpura[J].{H}Blood,2008,(1):11-18.
  • 6Sanchez-Luceros A,Farias CE,Amaral MM. Von Willebrand factorcleaving protease (ADAMTS13) activity in normal non-pregnant women,pregnant and post-delivery women[J].{H}Thrombosis and Haemostasis,2004,(6):1320-1326.
  • 7Hori Y,Hayakawa M,Isonishi A. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant:implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment[J].{H}TRANSFUSION,2013,(12):3192-3202.
  • 8Kondo H,Imamura Z. Effects of intravenous immunoglobulin in a patient with intermittent thrombotic thrombocytopenic purpura[J].{H}British Journal of Haematology,2000,(3):880-882.
  • 9Guzman Moreno R. B-cell depletion in autoimmune diseases.Advances in autoimmunity[J].{H}Autoimmunity Reviews,2009,(7):585-590.
  • 10Chemnitz JM,Uener J,Hallek M. Long-term follow up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab[J].{H}Annals of Hematology,2010,(10):1029-1033.

二级参考文献5

  • 1苏健,白霞,刘芳,高维强,余自强,王兆钺,阮长耿.血管性血友病因子裂解酶功能检测在血栓性血小板减少性紫癜诊断中的意义[J].中华检验医学杂志,2006,29(5):414-416. 被引量:1
  • 2SADLER J E. Von Willebrand factor,ADAMTS13,and thrombotic thrombocytopenic purpura[J]. Blood,2008,112:11-18.
  • 3SADLER J E, PONCZ M. Antibody-mediated throm-botic disorders : thrombotic thrombocytopenic purpuraand heparin-induced thrombocytopenia[M]//KAUS-HANSKY K,LICHTMAN M A’BEULTER E,et al.Williams Hematology. 8th ed. The McGraw-HillCompanies. Inc,2010:2163 - 2183.
  • 4KOKAME K,NOBE Y’KOKUBO Y,et al. FRETS-VWF73,a first fluorogenic substrate for ADAMTS13assay[J]. Br J Haematol, 2005,129 :93 -100.
  • 5BRESIN E,GASTOLDI S,DAINA E,et al. Ritux-imab as pre-emptive treatment in patients with throm-botic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies [J]. Thromb Haemost,2009,101:233-238.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部